Voclosporin

Basic Information

Item Value
DrugBank ID DB11693
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 29

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 primary release disorder of platelets KG + DL
2 Glanzmann thrombasthenia KG + DL
3 pseudo-von Willebrand disease KG + DL
4 dermatitis KG + DL
5 renal osteodystrophy KG + DL
6 exanthem (disease) KG + DL
7 severe nonproliferative diabetic retinopathy KG + DL
8 neonatal dermatomyositis KG + DL
9 acrodermatitis chronica atrophicans KG + DL
10 non-renal secondary hyperparathyroidism KG + DL
11 amyopathic dermatomyositis KG + DL
12 impaired renal function disease KG + DL
13 secondary interstitial lung disease specific to childhood associated with a connective tissue disease KG + DL
14 indolent plasma cell myeloma KG + DL
15 hyperparathyroidism, transient neonatal KG + DL
16 acne keloid KG + DL
17 hydroa vacciniforme, familial KG + DL
18 bronchitis KG + DL
19 plasma cell myeloma KG + DL
20 ulcerative colitis (disease) KG + DL
21 bone remodeling disease KG + DL
22 psoriasis KG + DL
23 hereditary persistence of fetal hemoglobin-sickle cell disease syndrome KG + DL
24 sickle cell-hemoglobin c disease syndrome KG + DL
25 sickle cell-hemoglobin E disease syndrome KG + DL
26 sickle cell-beta-thalassemia disease syndrome KG + DL
27 sickle cell-hemoglobin d disease syndrome KG + DL
28 congenital hypotrichosis with juvenile macular dystrophy KG + DL
29 biotin metabolic disease KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.